{"id":31768,"date":"2023-01-13T11:32:26","date_gmt":"2023-01-13T17:32:26","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=31768"},"modified":"2023-01-13T11:32:26","modified_gmt":"2023-01-13T17:32:26","slug":"brakke-consulting-viewpoint-january-13-2023","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/","title":{"rendered":"Brakke Consulting Viewpoint 13 de janeiro de 2023"},"content":{"rendered":"

A inova\u00e7\u00e3o parece estar na vanguarda de 2023. Na semana passada, ouvimos falar da primeira vacina para abelhas (da Dalan Animal Health); e o primeiro pentosano injet\u00e1vel aprovado para osteoartrite equina (da Anzac Animal Health). Esta semana, Zoetis' Solensia foi lan\u00e7ado, juntamente com v\u00e1rias novas terapias regenerativas.<\/p>\n

Grande parte da inova\u00e7\u00e3o no espa\u00e7o de sa\u00fade animal de hoje parece originar-se de startups, e n\u00e3o de l\u00edderes estabelecidos em sa\u00fade animal. Embora o desenvolvimento da Solensia tenha sido conclu\u00eddo pela Zoetis, a tecnologia foi adquirida quando a Zoetis comprou a startup de biotecnologia Nexvet Biopharma h\u00e1 v\u00e1rios anos. Os demais produtos citados foram todos desenvolvidos por startups de sa\u00fade animal. \u00c9 emocionante ver tantos produtos novos, especialmente aqueles que representam novas solu\u00e7\u00f5es para desafios \u00fanicos.<\/p>\n

Estou ansioso para participar da reuni\u00e3o VMX da pr\u00f3xima semana e aprender que outras inova\u00e7\u00f5es est\u00e3o por vir.<\/p>\n

Lynn Fondon<\/em><\/p>","protected":false},"excerpt":{"rendered":"

A inova\u00e7\u00e3o parece estar na vanguarda de 2023. Na semana passada, ouvimos falar da primeira vacina para abelhas (da Dalan Animal Health); e o primeiro pentosano injet\u00e1vel aprovado para osteoartrite equina (da Anzac Animal Health). Esta semana, o Solensia da Zoetis foi lan\u00e7ado, juntamente com diversas novas terapias regenerativas. Grande parte da inova\u00e7\u00e3o no espa\u00e7o atual da sa\u00fade animal parece originar-se de startups, e n\u00e3o de l\u00edderes estabelecidos em sa\u00fade animal. Embora o desenvolvimento da Solensia tenha sido conclu\u00eddo pela Zoetis, a tecnologia foi adquirida quando a Zoetis comprou a startup de biotecnologia Nexvet Biopharma, h\u00e1 v\u00e1rios anos. Os demais produtos citados foram todos desenvolvidos por startups de sa\u00fade animal. \u00c9 emocionante ver tantos produtos novos, especialmente aqueles que representam novas solu\u00e7\u00f5es para desafios \u00fanicos. Estou ansioso para participar da reuni\u00e3o VMX da pr\u00f3xima semana e saber que outras inova\u00e7\u00f5es est\u00e3o surgindo. Lynn Fondon<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-31768","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"Innovation seems to be the at the forefront of 2023. Last week, we heard about the first-ever vaccine for honeybees (from Dalan Animal Health); and the first-ever injectable pentosan approved for equine osteoarthritis (from Anzac Animal Health). This week, Zoetis\u2019 Solensia was launched, along with several novel regenerative therapies. Much of the innovation in today\u2019s animal health space seems to originate from startups rather than the established animal health leaders. While Solensia\u2019s development was completed by Zoetis, the technology was acquired when Zoetis bought biotech startup Nexvet Biopharma several years ago. The other products mentioned were all developed by animal health startups.\u00a0 It\u2019s exciting to see so many new products, especially those that represent new solutions to unique challenges. I\u2019m looking forward to attending next week\u2019s VMX meeting, and learning what other innovations are coming our way. Lynn Fondon\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-13T17:32:26+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Consulting Viewpoint January 13, 2023\",\"datePublished\":\"2023-01-13T17:32:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\"},\"wordCount\":147,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2023-01-13T17:32:26+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Consulting Viewpoint January 13, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"Innovation seems to be the at the forefront of 2023. Last week, we heard about the first-ever vaccine for honeybees (from Dalan Animal Health); and the first-ever injectable pentosan approved for equine osteoarthritis (from Anzac Animal Health). This week, Zoetis\u2019 Solensia was launched, along with several novel regenerative therapies. Much of the innovation in today\u2019s animal health space seems to originate from startups rather than the established animal health leaders. While Solensia\u2019s development was completed by Zoetis, the technology was acquired when Zoetis bought biotech startup Nexvet Biopharma several years ago. The other products mentioned were all developed by animal health startups.\u00a0 It\u2019s exciting to see so many new products, especially those that represent new solutions to unique challenges. I\u2019m looking forward to attending next week\u2019s VMX meeting, and learning what other innovations are coming our way. Lynn Fondon","og_url":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/","og_site_name":"Brakke Consulting Website","article_published_time":"2023-01-13T17:32:26+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Consulting Viewpoint January 13, 2023","datePublished":"2023-01-13T17:32:26+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/"},"wordCount":147,"articleSection":["Viewpoints"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/","url":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2023-01-13T17:32:26+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-consulting-viewpoint-january-13-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Consulting Viewpoint January 13, 2023"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/31768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=31768"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/31768\/revisions"}],"predecessor-version":[{"id":31769,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/31768\/revisions\/31769"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=31768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=31768"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=31768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}